Patents by Inventor Junkoh YAMAMOTO

Junkoh YAMAMOTO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nuclear magnetic resonance diagnostic agent, and method for detecting or diagnosing state of cell, tissue or organ in subject using same
    Patent number: 11633505
    Abstract: [Problem] To provide a nuclear magnetic resonance diagnostic agent that has a lower toxicity to organisms and reduced side effects and yet has a site specificity toward a specific cell, tissue, organ, etc. [Solution] When ALA or an ALA derivative is administered in vivo, a metabolite thereof is accumulated in a specific cell, tissue, organ, etc. Focusing on this phenomenon, a nuclear magnetic resonance analysis was performed on a site wherein the metabolite of ALA that had been administered in vivo would be possibly accumulated. As a result, it was surprisingly found that ALA and an ALA derivative are useful as a diagnostic agent whereby the aforesaid problem can be solved.
    Type: Grant
    Filed: December 9, 2013
    Date of Patent: April 25, 2023
    Assignees: National University Corporation Kumamoto University, University of Occupational and Enviromental Health, Japan, SBI Pharmaceuticals Co., Ltd.
    Inventors: Tetsuya Yoneda, Shigeru Nishizawa, Junkoh Yamamoto, Tohru Tanaka, Hidenori Itoh
  • COMPOSITION FOR INDUCING TUMOR IMMUNITY
    Publication number: 20170056351
    Abstract: [Problem to be Solved] It is an object of the present invention to provide a composition, which induces immunity to tumor cells and is also able to induce inhibition of tumor growth. [Solution] Provided is a composition for inducing tumor immunity, comprising ALAs.
    Type: Application
    Filed: February 19, 2015
    Publication date: March 2, 2017
    Inventors: Shigeru NISHIZAWA, Junkoh YAMAMOTO, Tohru TANAKA
  • NUCLEAR MAGNETIC RESONANCE DIAGNOSTIC AGENT, AND METHOD FOR DETECTING OR DIAGNOSING STATE OF CELL, TISSUE OR ORGAN IN SUBJECT USING SAME
    Publication number: 20150320888
    Abstract: [Problem] To provide a nuclear magnetic resonance diagnostic agent that has a lower toxicity to organisms and reduced side effects and yet has a site specificity toward a specific cell, tissue, organ, etc. [Solution] When ALA or an ALA derivative is administered in vivo, a metabolite thereof is accumulated in a specific cell, tissue, organ, etc. Focusing on this phenomenon, a nuclear magnetic resonance analysis was performed on a site wherein the metabolite of ALA that had been administered in vivo would be possibly accumulated. As a result, it was surprisingly found that ALA and an ALA derivative are useful as a diagnostic agent whereby the aforesaid problem can be solved.
    Type: Application
    Filed: December 9, 2013
    Publication date: November 12, 2015
    Inventors: Tetsuya YONEDA, Shigeru NISHIZAWA, Junkoh YAMAMOTO, Tohru TANAKA, Hidenori ITOH